First antiviral drug gets green light to fight COVID-19 56 SHARES Share it! Share TweetBy MB OnlineFapilavir, the first drug developed in China with the potential effect of treating coronavirus disease 2019 (COVID-19), has been approved for marketing, Global Times reported. According to multiple reports, Fapilavir is one of three medicines that showed good effects in clinical trials. On Monday, the death toll from COVID-19 had risen to 1,523, while the number of confirmed cases reached 66,492.

Source: Manila Bulletin February 17, 2020 12:06 UTC